<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04368364</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-20-0143</org_study_id>
    <nct_id>NCT04368364</nct_id>
  </id_info>
  <brief_title>A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks (QLB)vs Intrathecal Morphine(ITM) for Post Cesarean Section Pain</brief_title>
  <official_title>A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks vs Intrathecal Morphine for Post Cesarean Section Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      the purpose of this study is to compare opioid consumption in morphine equivalents between
      the groups that received postoperative analgesia with intrathecal morphine versus US guided
      QL blocks versus US guided QL catheters
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total narcotic consumption in morphine equivalents (in milligrams)</measure>
    <time_frame>upto 72 hours post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total narcotic consumption in morphine equivalents (in milligrams)</measure>
    <time_frame>12,24,48 hours post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain as measured by the numerical pain score (NPS)</measure>
    <time_frame>6, 12, 24, 48 and 72 hours post surgery</time_frame>
    <description>NPS is a 11-point scale with a higher number indicating more severe pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients showing side effects of pruritus</measure>
    <time_frame>24, 48 and 72 hours post surgery</time_frame>
    <description>This numeric scale is a 11-point scale with a higher number indicating an extremely severe side effect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients showing side effects of nausea</measure>
    <time_frame>24, 48 and 72 hours post surgery</time_frame>
    <description>This numeric scale is a 11-point scale with a higher number indicating an extremely severe side effect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients showing side effects of vomiting</measure>
    <time_frame>24, 48 and 72 hours post surgery</time_frame>
    <description>This numeric scale is a 11-point scale with a higher number indicating an extremely severe side effect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients showing side effects of sedation</measure>
    <time_frame>24, 48 and 72 hours post surgery</time_frame>
    <description>This numeric scale is a 11-point scale with a higher number indicating an extremely severe side effect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction will be measured on a Likert scale (5 points) ranging form extremely satisfied to not satisfied.</measure>
    <time_frame>48 and 72 hours post surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Group 1 (Control group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2(Bupivacaine hydrochloride group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3 (ropivacaine hydrochloride group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal morphine sulfate (ITM)</intervention_name>
    <description>Spinal anesthesia with ITM + US guided QLB single shot sham block + QLB catheters with no continuous infusion</description>
    <arm_group_label>Group 1 (Control group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine hydrochloride</intervention_name>
    <description>Spinal anesthesia without ITM + US guided QLB single shot with bupivacaine hydrochloride + QLB catheters with no continuous infusion</description>
    <arm_group_label>Group 2(Bupivacaine hydrochloride group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine hydrochloride</intervention_name>
    <description>Spinal anesthesia without ITM + US guided QLB single shot with bupivacaine hydrochloride + QLB catheters continuously infusing 0.2% ropivacaine hydrochloride</description>
    <arm_group_label>Group 3 (ropivacaine hydrochloride group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective C section via Pfannenstiel incision

          -  Living singleton pregnancy

          -  Gestation week at least 37 weeks

          -  American Society of Anesthesiologists (ASA) status 1, 2 and 3

          -  Primary and secondary C sections

        Exclusion Criteria:

          -  Chronic pain

          -  Opioid tolerant patients

          -  Allergy to drugs used in the study.

          -  Cognitive dysfunction

          -  BMI &gt; 40

          -  Coagulation disorder

          -  Local infection

          -  Inability to tolerate oral medication

          -  Previous intra-abdominal surgery

          -  Patients who will receive a combined spinal epidural for their C section

          -  Local anesthetics injected at any other fascial plane except the QLB plane (for e.g.-
             local wound infiltration by surgeon)

          -  Patients who received sedation or general anesthesia during their C section
             (midazolam, ketamine, fentanyl, propofol, hydromorphone)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sudipta Sen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sudipta Sen, MD</last_name>
    <phone>(713) 500-6200</phone>
    <email>Sudipta.Sen@uth.tmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Sudipta Sen, MD</last_name>
      <phone>713-500-6200</phone>
      <email>Sudipta.Sen@uth.tmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 24, 2020</study_first_submitted>
  <study_first_submitted_qc>April 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2020</study_first_posted>
  <last_update_submitted>April 28, 2020</last_update_submitted>
  <last_update_submitted_qc>April 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Sudipta Sen</investigator_full_name>
    <investigator_title>Fellow</investigator_title>
  </responsible_party>
  <keyword>post c section pain</keyword>
  <keyword>pain control after baby</keyword>
  <keyword>nerve block for post delivery pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

